N. Boulos

发表

A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease.

Heather L. Mulder, Jason R. Hodges, Celeste K. Kanne, 2021, Blood advances.

Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.

M. Roussel, Yoon-Jae Cho, R. Gilbertson, 2016, Cancer cell.

Deriving therapies for children with primary CNS tumors using pharmacokinetic modeling and simulation of cerebral microdialysis data.

C. Stewart, D. Turner, N. Boulos, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

UPLC-MS-ELSD-PDA as a powerful dereplication tool to facilitate compound identification from small-molecule natural product libraries.

A. Shelat, R. Gilbertson, Xing-Cong Li, 2014, Journal of natural products.

A Preclinical Multidisciplinary Brain Tumor Board

M. Roussel, T. Merchant, A. Shelat, 2017 .

Simvastatin Hydroxy Acid Fails to Attain Sufficient Central Nervous System Tumor Exposure to Achieve a Cytotoxic Effect: Results of a Preclinical Cerebral Microdialysis Study

R. Gilbertson, C. Stewart, P. Vuppala, 2016, Drug Metabolism and Disposition.

Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication

Jennifer M Murphy, M. Phelps, A. Lavie, 2014, The Journal of experimental medicine.

Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation.

J. Lunec, M. Tilby, W. Andrews, 2013, Cancer letters.

Orthotopic models of pediatric brain tumors in zebrafish

Michael R. Taylor, D. Ellison, R. Gilbertson, 2014, Oncogene.

An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes

D. Ellison, R. Gilbertson, D. Finkelstein, 2015, Nature Genetics.

Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Heather L. Mulder, M. Relling, J. Rehg, 2011, Blood.

An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma.

W. Yung, A. Shelat, D. Ellison, 2011, Cancer cell.

A Screening-Based Approach to Circumvent Tumor Microenvironment-Driven Intrinsic Resistance to BCR-ABL+ Inhibitors in Ph+ Acute Lymphoblastic Leukemia

A. Shelat, R. Guy, R. Williams, 2014, Journal of biomolecular screening.

Establishing a Preclinical Multidisciplinary Board for Brain Tumors

M. Roussel, T. Merchant, A. Shelat, 2018, Clinical Cancer Research.

Preclinical studies of 5-fluoro-2′-deoxycytidine and tetrahydrouridine in pediatric brain tumors

M. Roussel, A. Shelat, R. Gilbertson, 2015, Journal of Neuro-Oncology.

Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study

R. Gilbertson, K. M. Mohankumar, C. Stewart, 2015, Cancer Chemotherapy and Pharmacology.

Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma.

R. Gilbertson, K. Wright, A. Gajjar, 2015, Neuro-oncology.

Whole-Body Physiologically Based Pharmacokinetic Model for Nutlin-3a in Mice after Intravenous and Oral Administration

Fan Zhang, Fangyi Zhu, R Kiplin Guy, 2011, Drug Metabolism and Disposition.

Deriving therapies for children with primary CNS tumors using pharmacokinetic modeling and simulation of cerebral microdialysis data.

N. Boulos, M. Jacus, S. Throm, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.